The role of vitamin D in the pathogenesis and treatment of osteoporosis

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

It is well recognized that patients with postmenopausal osteoporosis usually exhibit some degree of calcium malabsorption and commonly have low serum concentrations of 1,25-dihydroxyvitamin D (calcitriol). Administration of calcitriol has been shown to normalize calcium absorption in patients with osteoporosis and, over the long term may have a stimulating effect on bone formation. Clinical trials have shown a significant reduction in osteoporotic fractures among calcitriol-treated patients. Hypercalcemia and hypercalciuria are infrequent complications of calcitriol therapy with physiologic doses (0.25 μg twice daily), and are most commonly related to excessive calcium intake (i.e., > 1000 mg daily).

Original languageEnglish
Pages (from-to)15-18
Number of pages4
JournalJournal of Rheumatology
Volume23
Issue numberSUPPL. 45
Publication statusPublished - Aug 1996

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology

Cite this